Our data demonstrate a dysregulation of the molecular clock system in PBMCs from participants with type 2 diabetes, manifested by a decrease in CLOCK, CRY1, p-BMAL1 and PER2 protein levels and an increase in BMAL1 and NR1D1 mRNA levels. The gene discussed is PER2; the disease is type 2 diabetes mellitus.